![]() | |
Clinical data | |
---|---|
Other names | Tropine benzylate, BAT, TB, #9447, BETE, BTE, Glykin, Glypin |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.125.953 |
Chemical and physical data | |
Formula | C22H25NO3 |
Molar mass | 351.446 g·mol−1 |
3D model (JSmol) | |
| |
|
Tropine benzilate also known as glipin is an ester formed between tropine and benzilic acid. [1] Like its structural relatives such as atropine and scopolamine, tropine benzilate is considered a muscarinic antagonist, meaning it binds to and blocks muscarinic acetylcholine receptors in the nervous system and various tissues.
The substance was first described in 1936 and was shown to relax smooth muscle and block signals from the vagus nerve. [2] It was also later shown to block stomach acid secretion in dogs. [3]
It is a chemical deliriant similar to two related substances, namely 3-quinuclidinyl benzilate and CS-27349. Atropine is also based on tropine alkaloid but differs in the structure in that it contains tropic acid and not benzilic acid for the aromatic portion of the ester moiety. Tropine benzilate is less commonly sold as a tertiary amine, but is usually encountered as the quaternary amine Flutropium bromide.
Tropine benzilate may be synthesized by reacting tropine with methyl benzilate in a transesterification reaction. [4]